Free Trial

Nomura (NYSE:NMR) Lowered to "Hold" Rating by StockNews.com

Nomura logo with Finance background

StockNews.com downgraded shares of Nomura (NYSE:NMR - Free Report) from a buy rating to a hold rating in a research note released on Monday morning.

Nomura Price Performance

Shares of NMR stock traded up $0.05 during trading on Monday, hitting $5.56. The company had a trading volume of 873,228 shares, compared to its average volume of 770,983. Nomura has a 52 week low of $4.66 and a 52 week high of $6.99. The stock has a market capitalization of $16.52 billion, a price-to-earnings ratio of 7.94, a price-to-earnings-growth ratio of 0.30 and a beta of 0.77. The company has a quick ratio of 1.11, a current ratio of 1.17 and a debt-to-equity ratio of 7.52. The stock's 50-day moving average is $5.95 and its two-hundred day moving average is $5.96.

Nomura (NYSE:NMR - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The financial services provider reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.03). The company had revenue of $7.08 billion for the quarter, compared to analysts' expectations of $451.20 billion. Nomura had a net margin of 7.96% and a return on equity of 9.19%. As a group, analysts predict that Nomura will post 0.76 EPS for the current fiscal year.

Institutional Trading of Nomura

Hedge funds and other institutional investors have recently bought and sold shares of the company. Donald Smith & CO. Inc. lifted its holdings in shares of Nomura by 44.0% in the 4th quarter. Donald Smith & CO. Inc. now owns 9,318,383 shares of the financial services provider's stock worth $53,953,000 after acquiring an additional 2,846,601 shares during the last quarter. Northern Trust Corp lifted its stake in Nomura by 86.7% in the fourth quarter. Northern Trust Corp now owns 2,241,316 shares of the financial services provider's stock worth $12,977,000 after purchasing an additional 1,041,022 shares during the last quarter. Millennium Management LLC boosted its position in Nomura by 68.8% during the fourth quarter. Millennium Management LLC now owns 974,917 shares of the financial services provider's stock valued at $5,645,000 after buying an additional 397,415 shares during the period. Marshall Wace LLP grew its stake in shares of Nomura by 178.6% during the fourth quarter. Marshall Wace LLP now owns 615,924 shares of the financial services provider's stock valued at $3,566,000 after buying an additional 394,866 shares during the last quarter. Finally, Summit Global Investments purchased a new position in shares of Nomura in the fourth quarter worth about $1,428,000. Hedge funds and other institutional investors own 15.14% of the company's stock.

About Nomura

(Get Free Report)

Nomura Holdings, Inc provides various financial services to individuals, corporations, financial institutions, governments, and governmental agencies worldwide. It operates through three segments: Retail, Investment Management, and Wholesale. The Retail segment offers various financial products and investment consultation services.

Featured Stories

Should You Invest $1,000 in Nomura Right Now?

Before you consider Nomura, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nomura wasn't on the list.

While Nomura currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines